Market News

Yum! Brands heads into Q3 earnings with KFC expansion and international growth in focus, while Taco Bell U.S. faces sales and margin pressures.

Cut drug R&D time and costs through hybrid quantum tools, cloud access and strategic partnerships - accelerating molecular modeling, diagnostics and p...

BYOD, remote work and tighter data rules fuel mobile virtualization, while cloud, 5G and secure containers strengthen endpoint control across regulate...

CHICAGO, October 30, 2026--The board of directors of GATX Corporation (NYSE: GATX) today declared a quarterly dividend of $0.66 per common share, paya...

Vistra offers a cheaper valuation, but The Southern Company leads in dividends, debt management, profitability and stock performance.

Uber is expected to post another quarter of solid growth, with its Mobility and Delivery businesses continuing to drive performance.

Key TakeawaysGrok Bot’s daily users rose from under 100,000 in early September to over 600,000 by Oct. 26, and Elon Musk notes that the AI agent has n...

Bristol-Myers Squibb is downgraded to Hold as its current valuation appears optimistic ahead of looming patent cliffs. Read more on BMY stock here.

An $890 million LIFO reserve cushions the company against future metal price declines, a structural advantage that protects profitability in a volatil...

While competitors struggle with capital constraints, EastGroup's financial strength is reshaping its competitive position.

Loan repricing tailwinds and margin expansion position the bank to grow earnings without taking on additional credit risk.

Banking operations and non-title expansion are now funding margin growth when the core title business faces structural headwinds.

Margin expansion in property management and geographic diversification in restoration services show how operational discipline compounds returns.

AI-driven cost controls and a cleaner balance sheet position the bank to compound earnings faster as loan volumes expand.

AudioEye (AEYE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Teva's pivot from generics to branded drugs has succeeded, but keep an eye out for this potential headwind.

Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Human Papillomavirus (HPV) Genotyping Panels Market Global Report 2026" has been added to ResearchAndMarket...

Changes to the Supervisory Board of Apollo Group OÜ Liisi Znatokov will step down from the Supervisory Board of Apollo Group OÜ upon the expiry of her...

Investors got all they wanted and more. It still wasn't enough.

Why Kimberly-Clark’s new debt deal matters for equity investors Kimberly-Clark (KMB) just closed a private offering of US$4.9b in senior unsecured not...